Benzinga's Top #PreMarket Losers
November 06, 2013 at 08:20 AM EST
Curis (NASDAQ: CRIS ) dipped 18.97% to $3.16 in the pre-market session after the company reported Q3 financial results and provided CUDC-427 development update. Solazyme (NASDAQ: SZYM ) dipped 12.46% to $9.06 on Q3 results. PhotoMedex (NASDAQ: PHMD ) shares dropped 12.09% to $11.27 in pre-market trading after the